BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 25747480)

  • 1. Anti-inflammatory and cytoprotective properties of hydrogen sulfide.
    Gemici B; Wallace JL
    Methods Enzymol; 2015; 555():169-93. PubMed ID: 25747480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gaseous Mediators in Gastrointestinal Mucosal Defense and Injury.
    Wallace JL; Ianaro A; de Nucci G
    Dig Dis Sci; 2017 Sep; 62(9):2223-2230. PubMed ID: 28733867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrogen sulfide-based anti-inflammatory and chemopreventive therapies: an experimental approach.
    Flannigan KL; Wallace JL
    Curr Pharm Des; 2015; 21(21):3012-22. PubMed ID: 26004409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD47-dependent regulation of H₂S biosynthesis and signaling in T cells.
    Kaur S; Schwartz AL; Miller TW; Roberts DD
    Methods Enzymol; 2015; 555():145-68. PubMed ID: 25747479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrogen sulfide-based therapeutics and gastrointestinal diseases: translating physiology to treatments.
    Chan MV; Wallace JL
    Am J Physiol Gastrointest Liver Physiol; 2013 Oct; 305(7):G467-73. PubMed ID: 23868410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrogen sulfide-releasing anti-inflammatory drugs.
    Wallace JL
    Trends Pharmacol Sci; 2007 Oct; 28(10):501-5. PubMed ID: 17884186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic applications of organosulfur compounds as novel hydrogen sulfide donors and/or mediators.
    Gu X; Zhu YZ
    Expert Rev Clin Pharmacol; 2011 Jan; 4(1):123-33. PubMed ID: 22115353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory and cytoprotective actions of hydrogen sulfide: translation to therapeutics.
    Wallace JL; Blackler RW; Chan MV; Da Silva GJ; Elsheikh W; Flannigan KL; Gamaniek I; Manko A; Wang L; Motta JP; Buret AG
    Antioxid Redox Signal; 2015 Feb; 22(5):398-410. PubMed ID: 24635322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced chemopreventive effects of a hydrogen sulfide-releasing anti-inflammatory drug (ATB-346) in experimental colorectal cancer.
    Elsheikh W; Blackler RW; Flannigan KL; Wallace JL
    Nitric Oxide; 2014 Sep; 41():131-7. PubMed ID: 24747869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.
    Fiorucci S; Santucci L; Distrutti E
    Dig Liver Dis; 2007 Dec; 39(12):1043-51. PubMed ID: 17997373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogen sulphide synthesis in the rat and mouse gastrointestinal tract.
    Martin GR; McKnight GW; Dicay MS; Coffin CS; Ferraz JG; Wallace JL
    Dig Liver Dis; 2010 Feb; 42(2):103-9. PubMed ID: 19570733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H2S-releasing drugs: anti-inflammatory, cytoprotective and chemopreventative potential.
    Gemici B; Elsheikh W; Feitosa KB; Costa SK; Muscara MN; Wallace JL
    Nitric Oxide; 2015 Apr; 46():25-31. PubMed ID: 25461269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological and pathophysiological roles of hydrogen sulfide in the gastrointestinal tract.
    Wallace JL
    Antioxid Redox Signal; 2010 May; 12(9):1125-33. PubMed ID: 19769457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to non-steroid anti-inflammatory drugs (NSAIDs) and suppressing hydrogen sulfide synthesis leads to altered structure and impaired function of the oesophagus and oesophagogastric junction.
    Zayachkivska O; Bula N; Khyrivska D; Gavrilyuk E; Wallace JL
    Inflammopharmacology; 2015 Jun; 23(2-3):91-9. PubMed ID: 25711289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of inflammatory responses by hydrogen sulfide (H₂S) in ischemia/reperfusion injury.
    Sodha NR; Sellke FW
    Methods Enzymol; 2015; 555():127-44. PubMed ID: 25747478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogen sulfide in gastrointestinal and liver physiopathology.
    Cipriani S; Mencarelli A
    Inflamm Allergy Drug Targets; 2011 Apr; 10(2):92-102. PubMed ID: 21275897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A hydrogen sulfide-releasing cyclooxygenase inhibitor markedly accelerates recovery from experimental spinal cord injury.
    Campolo M; Esposito E; Ahmad A; Di Paola R; Wallace JL; Cuzzocrea S
    FASEB J; 2013 Nov; 27(11):4489-99. PubMed ID: 23901068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346).
    Wallace JL; Caliendo G; Santagada V; Cirino G
    Br J Pharmacol; 2010 Mar; 159(6):1236-46. PubMed ID: 20128814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced synthesis and diminished degradation of hydrogen sulfide in experimental colitis: a site-specific, pro-resolution mechanism.
    Flannigan KL; Ferraz JG; Wang R; Wallace JL
    PLoS One; 2013; 8(8):e71962. PubMed ID: 23940796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogen sulfide enhances ulcer healing in rats.
    Wallace JL; Dicay M; McKnight W; Martin GR
    FASEB J; 2007 Dec; 21(14):4070-6. PubMed ID: 17634391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.